Drug profile · INN
acrisorcin
AKRINOL
acrisorcin (AKRINOL) is a unknown. Route of administration: topical. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — acrisorcin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
acrisorcin (AKRINOL) is a unknown. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN acrisorcin
Brand AKRINOL
Mechanism Unknown
Route TOPICAL
Formulation CREAM
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is acrisorcin?
acrisorcin (AKRINOL) is a unknown. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for acrisorcin?
AKRINOL is a marketed brand name for acrisorcin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acrisorcin?
acrisorcin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.